GlassScriptPhysician profile
Draion M Burch
NPI 1255537015
$1,447.36
in general payments reported to CMS, 2019-2025
13 companies · $305 in 2025
The $305 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.11 · 2022: $170 · 2023: $584 · 2024: $335 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,125 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,124.74 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $207.57 | 2022-2025 | |
| Abbvie INC. | $201.29 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $198.76 | 2023-2024 | Veozah |
| Pfizer INC. | $187.04 | 2022-2024 | |
| Novo Nordisk INC | $176.19 | 2022-2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $148.04 | 2019-2025 | |
| Lilly USA, LLC | $87.96 | 2025 | Zepbound |
| Sage Therapeutics, LLC | $80.71 | 2024-2025 | Zurzuvae |
| Exact Sciences Corporation | $52.28 | 2024-2025 | Cologuard Collection Kit |
| Organon LLC | $35.65 | 2023-2024 | Nexplanon |
| Sumitomo Pharma America, INC. | $32.93 | 2025 | Myfembree, Gemtesa |
| Hologic Sales and Service, LLC | $26.99 | 2024 | Aptima, Thinprep 2000 Processor |
| Therapeuticsmd, INC. | $11.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Draion Burch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.